Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10701921.8Aexternal-prioritypatent/EP2389382B1/en
Application filed by Pfizer Inc.filedCriticalPfizer Inc.
Publication of CY1114108T1publicationCriticalpatent/CY1114108T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Η εφεύρεση παρέχει ενώσεις αναστολείς ΡDΕ9 του Τύπου (Ι) και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου τα R1, R2, R3, A και n είναι όπως ορίζεται εδώ. Επίσης παρέχονται φαρμακευτικές συνθέσεις που περιέχουν τις ενώσεις του Τύπου Ι και χρήσεις αυτών στην θεραπεία νευροεκφυλιστικών και γνωστικών διαταραχών, όπως ασθένεια Alzheimer και σχιζοφρένεια.The invention provides PDE9 inhibitor compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, A and n are as defined herein. Also provided are pharmaceutical compositions containing the compounds of Formula I and their uses in the treatment of neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia.
CY20131100559T2009-01-262013-07-04
AMINO-Heterocyclic Compounds Used as PDE9 Suspensions
CY1114108T1
(en)